Crash
Natural health product licensed in Canada
- Licence holder
- Pro Supps USA, LLC
- NPN or DIN-HM
- 80046536
- Status
- Active licence
- Licence date
- 26 November 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Valeriana officinalis Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 282 mg Potency : 0.8 % Valerenic acid | 70.5 mg | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 213.75 mg | Not calculated |
| Ester d'acide 5-monophosphorique de pyridoxal Source : 5-phosphate de pyridoxal | 0.5 mg | Not calculated |
| L-carnitine Source : L-tartrate de carnitine | 35.7 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 0.5 mg | Not calculated |
| Phosphatidylserine Source : Phosphatidylserine | 10 mg | Not calculated |
| 8,13,13b,14-Tétrahydro-14-méthylindolo[2',3':3,4]pyrido[2,1-b]quinazoline-5(7H)-one Source : Fruit | 10 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Gélatine, silice, Lécithine, Dioxyde de titanium, Bleu FD&C # 1, phosphate de dicalcium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Valerian helps to promote sleep. GABA helps to temporarily promote relaxation. Melatonin helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Melatonin helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Melatonin helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80046536
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.